Correlation Between Climb Bio and Vaccinex
Can any of the company-specific risk be diversified away by investing in both Climb Bio and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Climb Bio and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Climb Bio and Vaccinex, you can compare the effects of market volatilities on Climb Bio and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Climb Bio with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Climb Bio and Vaccinex.
Diversification Opportunities for Climb Bio and Vaccinex
Good diversification
The 3 months correlation between Climb and Vaccinex is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Climb Bio and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Climb Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Climb Bio are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Climb Bio i.e., Climb Bio and Vaccinex go up and down completely randomly.
Pair Corralation between Climb Bio and Vaccinex
Given the investment horizon of 90 days Climb Bio is expected to generate 0.86 times more return on investment than Vaccinex. However, Climb Bio is 1.17 times less risky than Vaccinex. It trades about 0.02 of its potential returns per unit of risk. Vaccinex is currently generating about -0.05 per unit of risk. If you would invest 259.00 in Climb Bio on October 21, 2024 and sell it today you would lose (64.00) from holding Climb Bio or give up 24.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.49% |
Values | Daily Returns |
Climb Bio vs. Vaccinex
Performance |
Timeline |
Climb Bio |
Vaccinex |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Climb Bio and Vaccinex Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Climb Bio and Vaccinex
The main advantage of trading using opposite Climb Bio and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Climb Bio position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.Climb Bio vs. Dogwood Therapeutics, | Climb Bio vs. Eupraxia Pharmaceuticals Common | Climb Bio vs. CERo Therapeutics Holdings | Climb Bio vs. Opus Genetics, |
Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |